Status:
UNKNOWN
General Anesthesia With and Without Muscle Relaxation and Muscle Strength Recovery
Lead Sponsor:
Clinical Hospital Centre Zagreb
Conditions:
Rocuronium
Muscle Weakness
Eligibility:
All Genders
18-65 years
Phase:
NA
Brief Summary
Neuromuscular blocking agents are often used during general anesthesia. Also, general anesthesia may be performed without use of neuromuscular blocking agents. Avoiding neuromuscular relaxation enabl...
Detailed Description
Rocuronium is well used neuromuscular blocking agent during general anesthesia. Although very often used, neuromuscular blocking agents may sometimes have consequence in form of residual neuromuscular...
Eligibility Criteria
Inclusion
- patients ASA status I-III for surgery under general anesthesia
- signed informed consent for participating in research
Exclusion
- neuromuscular disease
- poorly controled chronic or acute cardiovascular, respiratory or autoimmune disease
- known allergic reaction to any medication used in this research
- pregnancy
- refusal to participate in this research
Key Trial Info
Start Date :
April 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2022
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04760912
Start Date
April 1 2020
End Date
September 1 2022
Last Update
March 8 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UHCZagreb
Zagreb, Croatia, 10000